CP
Christopher P. Molineaux
DELAYED 1 MONTH
Director
Aclaris Therapeutics, Inc.
Filings
1
Companies
1
Latest
Jun 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Aclaris Therapeutics, Inc.
Christopher P. Molineaux
Director
Option Exercise
—
11,580 sh
Jun 8 8:15 PM
Jun 5, 2026